Leuthold Group’s GSK GSK Stock Holding History

Leuthold Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.09M	Sell	97,182 -5,323	-5%	-$282K	0.51%	81
2026 Q1	$5.66M	Buy	102,505 +2,147	+2%	+$116K	0.6%	68
2025 Q4	$4.92M	Buy	+100,358	New	+$4.68M	0.53%	78
2023 Q3	–	Sell	-6,300	Closed	-$225K	–	196
2023 Q2	$225K	Hold	6,300	–	–	0.03%	190
2023 Q1	$224K	Sell	6,300 -360	-5%	-$12.6K	0.03%	181
2022 Q4	$234K	Buy	+6,660	New	+$222K	0.03%	183
2022 Q3	–	Sell	-6,786	Closed	-$369K	–	191
2022 Q2	$369K	Buy	+6,786	New	+$375K	0.05%	157
2020 Q4	–	Sell	-8,873	Closed	-$417K	–	179
2020 Q3	$417K	Sell	8,873 -247	-3%	-$12.4K	0.06%	132
2020 Q2	$465K	Sell	9,120 -357	-4%	-$18.3K	0.07%	115
2020 Q1	$449K	Sell	9,477 -880	-8%	-$46.9K	0.08%	119
2019 Q4	$608K	Buy	+10,357	New	+$576K	0.08%	117
2013 Q4	–	Sell	-7,608	Closed	-$477K	–	251
2013 Q3	$477K	Sell	7,608 -921	-11%	-$59.3K	0.04%	278
2013 Q2	$533K	Buy	+8,529	New	+$541K	0.05%	289

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Leuthold Group's GSK Position: Q2 2026 in Review

Leuthold Group reduced its GSK (GSK) stake by 5.2% in Q2 2026, selling an estimated $282K and leaving 97,182 shares worth $5.09M. The position accounts for 0.51% of the portfolio, ranked #81.

Leuthold Group first reported a position in GSK in Q2 2013 and has held it in 13 quarters since. The position peaked at $5.66M in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Leuthold Group held 97,182 shares of GSK worth $5.09M as of Q2 2026.
Leuthold Group sold 5,323 GSK shares in Q2 2026, an estimated $282K.
GSK made up 0.51% of Leuthold Group's portfolio in Q2 2026, its #81 holding.
Leuthold Group first reported a position in GSK in Q2 2013 and has held it in 13 quarters since.
Leuthold Group's GSK position peaked at $5.66M in Q1 2026.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Leuthold Group's 13F filing for Q2 2026, filed 4 Aug 2026.